4//SEC Filing
SHARMA TOM 4
Accession 0001842718-23-000048
CIK 0001842718other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 5:19 PM ET
Size
16.1 KB
Accession
0001842718-23-000048
Insider Transaction Report
Form 4
SHARMA TOM
Chief Product Officer
Transactions
- Exercise/Conversion
Common Stock, $0.001 par value
2023-05-04$8.58/sh+4,157$35,667→ 59,196 total - Sale
Common Stock, $0.001 par value
2023-05-05$17.51/sh−200$3,502→ 55,039 total - Sale
Common Stock, $0.001 par value
2023-05-04$16.00/sh−4,157$66,512→ 55,039 total - Exercise/Conversion
Common Stock, $0.001 par value
2023-05-05$8.58/sh+53,546$459,425→ 108,585 total - Sale
Common Stock, $0.001 par value
2023-05-05$16.79/sh−53,346$895,679→ 55,239 total - Exercise/Conversion
Options (Right to Buy)
2023-05-04−4,157→ 199,344 totalExercise: $8.58Exp: 2030-11-02→ Common Stock, $0.001 par value (4,157 underlying) - Exercise/Conversion
Options (Right to Buy)
2023-05-05−53,546→ 145,798 totalExercise: $8.58Exp: 2030-11-02→ Common Stock, $0.001 par value (53,546 underlying)
Footnotes (4)
- [F1]The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Such Rule 10b5-1 trading plan was adopted on December 15, 2022.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.48 to $17.47 per share. The reporting person undertakes to provide to Integral Ad Science Holding Corp., any security holder of Integral Ad Science Holding Corp. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.50 to $17.51 per share. The reporting person undertakes to provide to Integral Ad Science Holding Corp., any security holder of Integral Ad Science Holding Corp. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F4]These options were granted on November 2, 2020 and vest 25% after one year and in equal quarterly installments over the next three years.
Documents
Issuer
INTEGRAL AD SCIENCE HOLDING CORP.
CIK 0001842718
Entity typeother
Related Parties
1- filerCIK 0001861730
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 5:19 PM ET
- Size
- 16.1 KB